Wells Kenneth, Sherbourne Cathy, Duan Naihua, Unützer Jürgen, Miranda Jeanne, Schoenbaum Michael, Ettner Susan L, Meredith Lisa S, Rubenstein Lisa
RAND Corporation, 1700 Main St., P.O. Box 2138, Santa Monica, CA 90407-2138, USA.
Am J Psychiatry. 2005 Jun;162(6):1149-57. doi: 10.1176/appi.ajp.162.6.1149.
Quality improvement programs for depression can improve outcomes, but the utility of including patients with subthreshold depression in quality improvement programs is unclear. The authors examined 57-month effects of quality improvement on clinical outcomes and mental health care utilization of primary care patients with depressive disorder and subthreshold depression.
In a group-level, randomized, controlled trial, 46 primary care clinics were randomly assigned to provide usual care or care with a quality improvement intervention that included provider training and other resources for either medication management (medications quality improvement) or evidence-based psychotherapy (therapy quality improvement). Among 1,356 enrolled depressed patients, 991 completed the 57-month follow-up interview (604 patients with depressive disorder and 387 with subthreshold depression). Outcomes measured at 57 months were presence of probable depressive disorder, unmet need for appropriate care (untreated probable disorder), and mental health care utilization in the prior 6 months.
Among patients with subthreshold depression at baseline, those seen in clinics with quality improvement programs with special resources for therapy were less likely to have probable depressive disorder and unmet need for care at follow-up, compared with those seen in clinics that provided usual care. Among patients with depressive disorder at baseline, those seen in clinics with quality improvement programs with special resources for medication management were less likely to have unmet need for care at follow-up, compared with those seen in clinics that provided usual care. Patients with subthreshold depression at baseline seen in clinics with a quality improvement intervention were less likely at follow-up to have had a mental health visit (in primary care or specialty care, depending on the intervention) in the prior 6 months.
Relative to usual care, quality improvement interventions improved 57-month outcomes (probable depression, unmet need, or both) for primary care patients with depressive disorder and subthreshold depression and lowered use of mental health visits for those with subthreshold depression. The results highlight the feasibility and utility of including patients with subthreshold depression in such programs.
抑郁症质量改进项目可改善治疗效果,但将亚阈值抑郁症患者纳入质量改进项目的效用尚不清楚。作者研究了质量改进对患有抑郁症和亚阈值抑郁症的初级保健患者临床结局及精神卫生保健利用情况的57个月影响。
在一项组水平随机对照试验中,46家初级保健诊所被随机分配提供常规护理或采用质量改进干预措施的护理,该干预措施包括针对药物管理(药物质量改进)或循证心理治疗(治疗质量改进)的提供者培训及其他资源。在1356名登记的抑郁症患者中,991人完成了57个月的随访访谈(604名抑郁症患者和387名亚阈值抑郁症患者)。在57个月时测量的结局包括可能的抑郁症的存在、未满足的适当护理需求(未治疗的可能疾病)以及前6个月的精神卫生保健利用情况。
在基线时患有亚阈值抑郁症的患者中,与接受常规护理的诊所中的患者相比,在设有针对治疗的特殊资源的质量改进项目诊所中接受治疗的患者在随访时患可能抑郁症和未满足护理需求的可能性较小。在基线时患有抑郁症的患者中,与接受常规护理的诊所中的患者相比,在设有针对药物管理的特殊资源的质量改进项目诊所中接受治疗的患者在随访时未满足护理需求的可能性较小。在设有质量改进干预措施的诊所中接受治疗的基线时患有亚阈值抑郁症的患者在随访时在前6个月进行精神卫生就诊(在初级保健或专科护理中,取决于干预措施)的可能性较小。
相对于常规护理,质量改进干预措施改善了患有抑郁症和亚阈值抑郁症的初级保健患者的57个月结局(可能的抑郁症、未满足的需求或两者),并降低了亚阈值抑郁症患者的精神卫生就诊使用率。结果突出了将亚阈值抑郁症患者纳入此类项目的可行性和效用。